Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte densityJohn Bradley, Teun Bousema, William J. Stone et al.|eLife|2018Cited by 143
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialAlassane Dicko, Teun Bousema, Koualy Sanogo et al.|The Lancet Infectious Diseases|2018Cited by 126
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trialAlassane Dicko, Roly Gosling, Joelle Brown et al.|The Lancet Infectious Diseases|2016Cited by 98
A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytesLisette Meerstein‐Kessel, Teun Bousema, Chiara Andolina et al.|Malaria Journal|2018Cited by 73